nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—ABCB1—breast cancer	0.243	1	CbGaD
Cilazapril—ABCB1—Toremifene—breast cancer	0.0732	0.223	CbGbCtD
Cilazapril—ABCB1—Lapatinib—breast cancer	0.0534	0.162	CbGbCtD
Cilazapril—ABCB1—Vinorelbine—breast cancer	0.0296	0.0901	CbGbCtD
Cilazapril—ABCB1—Tamoxifen—breast cancer	0.0267	0.0813	CbGbCtD
Cilazapril—ABCB1—Mitoxantrone—breast cancer	0.0261	0.0793	CbGbCtD
Cilazapril—ABCB1—Gemcitabine—breast cancer	0.023	0.0701	CbGbCtD
Cilazapril—ABCB1—Paclitaxel—breast cancer	0.0208	0.0633	CbGbCtD
Cilazapril—ABCB1—Irinotecan—breast cancer	0.0205	0.0624	CbGbCtD
Cilazapril—ABCB1—Vinblastine—breast cancer	0.0183	0.0555	CbGbCtD
Cilazapril—ABCB1—Docetaxel—breast cancer	0.015	0.0458	CbGbCtD
Cilazapril—ABCB1—Doxorubicin—breast cancer	0.0112	0.0341	CbGbCtD
Cilazapril—ABCB1—Methotrexate—breast cancer	0.0109	0.033	CbGbCtD
Cilazapril—ACE—umbilical vein—breast cancer	0.00697	0.156	CbGeAlD
Cilazapril—ACE—arm—breast cancer	0.00609	0.136	CbGeAlD
Cilazapril—SLC15A2—mammary gland—breast cancer	0.00232	0.0519	CbGeAlD
Cilazapril—SLC15A1—epithelium—breast cancer	0.00207	0.0462	CbGeAlD
Cilazapril—SLC15A1—endometrium—breast cancer	0.00185	0.0415	CbGeAlD
Cilazapril—ACE—embryo—breast cancer	0.00182	0.0406	CbGeAlD
Cilazapril—ACE—epithelium—breast cancer	0.00148	0.0331	CbGeAlD
Cilazapril—ACE—endometrium—breast cancer	0.00133	0.0297	CbGeAlD
Cilazapril—SLC15A1—endocrine gland—breast cancer	0.0013	0.0291	CbGeAlD
Cilazapril—ACE—pituitary gland—breast cancer	0.0012	0.0269	CbGeAlD
Cilazapril—ACE—adipose tissue—breast cancer	0.0012	0.0268	CbGeAlD
Cilazapril—SLC15A2—endometrium—breast cancer	0.00116	0.0259	CbGeAlD
Cilazapril—ACE—female reproductive system—breast cancer	0.0011	0.0246	CbGeAlD
Cilazapril—ACE—adrenal gland—breast cancer	0.00107	0.024	CbGeAlD
Cilazapril—SLC15A2—pituitary gland—breast cancer	0.00105	0.0235	CbGeAlD
Cilazapril—ACE—bone marrow—breast cancer	0.00104	0.0232	CbGeAlD
Cilazapril—ACE—female gonad—breast cancer	0.001	0.0224	CbGeAlD
Cilazapril—SLC15A2—female reproductive system—breast cancer	0.00096	0.0215	CbGeAlD
Cilazapril—SLC15A2—adrenal gland—breast cancer	0.000937	0.021	CbGeAlD
Cilazapril—ACE—endocrine gland—breast cancer	0.000932	0.0208	CbGeAlD
Cilazapril—SLC15A2—female gonad—breast cancer	0.000874	0.0195	CbGeAlD
Cilazapril—SLC15A2—endocrine gland—breast cancer	0.000812	0.0182	CbGeAlD
Cilazapril—Perindopril—BCHE—breast cancer	0.000722	0.197	CrCbGaD
Cilazapril—Benazepril—MTHFR—breast cancer	0.00068	0.186	CrCbGaD
Cilazapril—ACE—lymph node—breast cancer	0.000644	0.0144	CbGeAlD
Cilazapril—ABCB1—embryo—breast cancer	0.000639	0.0143	CbGeAlD
Cilazapril—Ramipril—BCHE—breast cancer	0.000616	0.168	CrCbGaD
Cilazapril—SLC15A2—lymph node—breast cancer	0.000562	0.0126	CbGeAlD
Cilazapril—ABCB1—epithelium—breast cancer	0.000522	0.0117	CbGeAlD
Cilazapril—ABCB1—endometrium—breast cancer	0.000468	0.0105	CbGeAlD
Cilazapril—ABCB1—uterus—breast cancer	0.000431	0.00964	CbGeAlD
Cilazapril—ABCB1—pituitary gland—breast cancer	0.000423	0.00947	CbGeAlD
Cilazapril—ABCB1—adipose tissue—breast cancer	0.000422	0.00943	CbGeAlD
Cilazapril—ABCB1—female reproductive system—breast cancer	0.000388	0.00867	CbGeAlD
Cilazapril—ABCB1—adrenal gland—breast cancer	0.000378	0.00846	CbGeAlD
Cilazapril—ABCB1—bone marrow—breast cancer	0.000366	0.00818	CbGeAlD
Cilazapril—ABCB1—female gonad—breast cancer	0.000353	0.00789	CbGeAlD
Cilazapril—ABCB1—endocrine gland—breast cancer	0.000328	0.00734	CbGeAlD
Cilazapril—Perindopril—ABCB1—breast cancer	0.000283	0.0771	CrCbGaD
Cilazapril—Nateglinide—PTGS1—breast cancer	0.000257	0.0701	CrCbGaD
Cilazapril—Lisinopril—ABCB1—breast cancer	0.000249	0.068	CrCbGaD
Cilazapril—ABCB1—lymph node—breast cancer	0.000227	0.00507	CbGeAlD
Cilazapril—Enalapril—CYP3A4—breast cancer	0.00022	0.0599	CrCbGaD
Cilazapril—Enalapril—ABCB1—breast cancer	0.000183	0.0499	CrCbGaD
Cilazapril—Nateglinide—CYP2D6—breast cancer	0.000175	0.0477	CrCbGaD
Cilazapril—Nateglinide—CYP3A4—breast cancer	0.00015	0.0409	CrCbGaD
Cilazapril—Nateglinide—ALB—breast cancer	0.000131	0.0357	CrCbGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ATP7B—breast cancer	0.00011	0.00213	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CASP7—breast cancer	0.000108	0.0021	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—IGFBP3—breast cancer	0.000108	0.0021	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—ACHE—breast cancer	0.000106	0.00205	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000102	0.00198	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—NCOA1—breast cancer	0.000102	0.00198	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—CTSD—breast cancer	0.0001	0.00194	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—THBS1—breast cancer	9.85e-05	0.00191	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CXCL12—breast cancer	9.76e-05	0.00189	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CD40—breast cancer	9.65e-05	0.00187	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CTLA4—breast cancer	9.51e-05	0.00185	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—TUBB3—breast cancer	9.35e-05	0.00182	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—breast cancer	9.35e-05	0.00181	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—BCHE—breast cancer	9.2e-05	0.00179	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—STMN1—breast cancer	9.17e-05	0.00178	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—HMOX1—breast cancer	9.17e-05	0.00178	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—RPS6—breast cancer	8.98e-05	0.00174	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—AGTR1—breast cancer	8.83e-05	0.00171	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—SMAD4—breast cancer	8.8e-05	0.00171	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—TUBB3—breast cancer	8.68e-05	0.00168	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—TCF7L2—breast cancer	8.56e-05	0.00166	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—breast cancer	8.05e-05	0.00156	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—PLAUR—breast cancer	8e-05	0.00155	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MRE11A—breast cancer	7.95e-05	0.00154	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—PLG—breast cancer	7.82e-05	0.00152	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC2A2—breast cancer	7.78e-05	0.00151	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—FST—breast cancer	7.75e-05	0.0015	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ABCG2—breast cancer	7.62e-05	0.00148	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—TERT—breast cancer	7.53e-05	0.00146	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC2A2—breast cancer	7.22e-05	0.0014	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—HIF1A—breast cancer	7.2e-05	0.0014	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ABCG2—breast cancer	7.08e-05	0.00137	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC28A1—breast cancer	7.07e-05	0.00137	CbGpPWpGaD
Cilazapril—Hypotension—Capecitabine—breast cancer	7.06e-05	0.000215	CcSEcCtD
Cilazapril—Insomnia—Docetaxel—breast cancer	7.06e-05	0.000215	CcSEcCtD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—LEP—breast cancer	7.03e-05	0.00136	CbGpPWpGaD
Cilazapril—Paraesthesia—Docetaxel—breast cancer	7.01e-05	0.000213	CcSEcCtD
Cilazapril—Erythema multiforme—Epirubicin—breast cancer	7e-05	0.000213	CcSEcCtD
Cilazapril—Alopecia—Methotrexate—breast cancer	7e-05	0.000213	CcSEcCtD
Cilazapril—Vomiting—Gemcitabine—breast cancer	6.99e-05	0.000213	CcSEcCtD
Cilazapril—Bradycardia—Doxorubicin—breast cancer	6.98e-05	0.000213	CcSEcCtD
Cilazapril—Dyspnoea—Docetaxel—breast cancer	6.96e-05	0.000212	CcSEcCtD
Cilazapril—Somnolence—Docetaxel—breast cancer	6.94e-05	0.000211	CcSEcCtD
Cilazapril—Rash—Gemcitabine—breast cancer	6.93e-05	0.000211	CcSEcCtD
Cilazapril—Dermatitis—Gemcitabine—breast cancer	6.93e-05	0.000211	CcSEcCtD
Cilazapril—Tinnitus—Epirubicin—breast cancer	6.91e-05	0.00021	CcSEcCtD
Cilazapril—Headache—Gemcitabine—breast cancer	6.89e-05	0.00021	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Capecitabine—breast cancer	6.88e-05	0.00021	CcSEcCtD
Cilazapril—Flushing—Epirubicin—breast cancer	6.88e-05	0.000209	CcSEcCtD
Cilazapril—Cardiac disorder—Epirubicin—breast cancer	6.88e-05	0.000209	CcSEcCtD
Cilazapril—Vomiting—Fluorouracil—breast cancer	6.87e-05	0.000209	CcSEcCtD
Cilazapril—Rhinitis—Doxorubicin—breast cancer	6.87e-05	0.000209	CcSEcCtD
Cilazapril—Dyspepsia—Docetaxel—breast cancer	6.87e-05	0.000209	CcSEcCtD
Cilazapril—Insomnia—Capecitabine—breast cancer	6.83e-05	0.000208	CcSEcCtD
Cilazapril—Hypoaesthesia—Doxorubicin—breast cancer	6.82e-05	0.000208	CcSEcCtD
Cilazapril—Rash—Fluorouracil—breast cancer	6.82e-05	0.000208	CcSEcCtD
Cilazapril—Dermatitis—Fluorouracil—breast cancer	6.81e-05	0.000207	CcSEcCtD
Cilazapril—Pharyngitis—Doxorubicin—breast cancer	6.8e-05	0.000207	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—TFRC—breast cancer	6.8e-05	0.00132	CbGpPWpGaD
Cilazapril—Paraesthesia—Capecitabine—breast cancer	6.78e-05	0.000207	CcSEcCtD
Cilazapril—Decreased appetite—Docetaxel—breast cancer	6.78e-05	0.000207	CcSEcCtD
Cilazapril—Hypersensitivity—Paclitaxel—breast cancer	6.78e-05	0.000207	CcSEcCtD
Cilazapril—Headache—Fluorouracil—breast cancer	6.77e-05	0.000206	CcSEcCtD
Cilazapril—Urinary tract disorder—Doxorubicin—breast cancer	6.77e-05	0.000206	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—breast cancer	6.76e-05	0.00131	CbGpPWpGaD
Cilazapril—Dysgeusia—Methotrexate—breast cancer	6.75e-05	0.000206	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Docetaxel—breast cancer	6.74e-05	0.000205	CcSEcCtD
Cilazapril—Dyspnoea—Capecitabine—breast cancer	6.74e-05	0.000205	CcSEcCtD
Cilazapril—Fatigue—Docetaxel—breast cancer	6.73e-05	0.000205	CcSEcCtD
Cilazapril—Angiopathy—Epirubicin—breast cancer	6.72e-05	0.000205	CcSEcCtD
Cilazapril—Urethral disorder—Doxorubicin—breast cancer	6.72e-05	0.000205	CcSEcCtD
Cilazapril—Nausea—Irinotecan—breast cancer	6.71e-05	0.000204	CcSEcCtD
Cilazapril—Nausea—Mitoxantrone—breast cancer	6.71e-05	0.000204	CcSEcCtD
Cilazapril—Immune system disorder—Epirubicin—breast cancer	6.69e-05	0.000204	CcSEcCtD
Cilazapril—Pain—Docetaxel—breast cancer	6.67e-05	0.000203	CcSEcCtD
Cilazapril—Constipation—Docetaxel—breast cancer	6.67e-05	0.000203	CcSEcCtD
Cilazapril—Dyspepsia—Capecitabine—breast cancer	6.65e-05	0.000203	CcSEcCtD
Cilazapril—Chills—Epirubicin—breast cancer	6.65e-05	0.000203	CcSEcCtD
Cilazapril—Arrhythmia—Epirubicin—breast cancer	6.62e-05	0.000202	CcSEcCtD
Cilazapril—Visual impairment—Doxorubicin—breast cancer	6.61e-05	0.000201	CcSEcCtD
Cilazapril—Asthenia—Paclitaxel—breast cancer	6.61e-05	0.000201	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—breast cancer	6.59e-05	0.00128	CbGpPWpGaD
Cilazapril—Decreased appetite—Capecitabine—breast cancer	6.57e-05	0.0002	CcSEcCtD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—NOS2—breast cancer	6.55e-05	0.00127	CbGpPWpGaD
Cilazapril—Alopecia—Epirubicin—breast cancer	6.55e-05	0.000199	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—NCOA2—breast cancer	6.54e-05	0.00127	CbGpPWpGaD
Cilazapril—Nausea—Gemcitabine—breast cancer	6.53e-05	0.000199	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Capecitabine—breast cancer	6.52e-05	0.000199	CcSEcCtD
Cilazapril—Fatigue—Capecitabine—breast cancer	6.51e-05	0.000198	CcSEcCtD
Cilazapril—Pruritus—Paclitaxel—breast cancer	6.51e-05	0.000198	CcSEcCtD
Cilazapril—Erythema multiforme—Doxorubicin—breast cancer	6.48e-05	0.000197	CcSEcCtD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC2A10—breast cancer	6.46e-05	0.00125	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC4A7—breast cancer	6.46e-05	0.00125	CbGpPWpGaD
Cilazapril—Constipation—Capecitabine—breast cancer	6.46e-05	0.000197	CcSEcCtD
Cilazapril—Pain—Capecitabine—breast cancer	6.46e-05	0.000197	CcSEcCtD
Cilazapril—Feeling abnormal—Docetaxel—breast cancer	6.43e-05	0.000196	CcSEcCtD
Cilazapril—Nausea—Fluorouracil—breast cancer	6.42e-05	0.000196	CcSEcCtD
Cilazapril—Ill-defined disorder—Methotrexate—breast cancer	6.39e-05	0.000195	CcSEcCtD
Cilazapril—Tinnitus—Doxorubicin—breast cancer	6.39e-05	0.000195	CcSEcCtD
Cilazapril—Gastrointestinal pain—Docetaxel—breast cancer	6.38e-05	0.000194	CcSEcCtD
Cilazapril—Anaemia—Methotrexate—breast cancer	6.37e-05	0.000194	CcSEcCtD
Cilazapril—Flushing—Doxorubicin—breast cancer	6.36e-05	0.000194	CcSEcCtD
Cilazapril—Cardiac disorder—Doxorubicin—breast cancer	6.36e-05	0.000194	CcSEcCtD
Cilazapril—Flatulence—Epirubicin—breast cancer	6.36e-05	0.000194	CcSEcCtD
Cilazapril—Tension—Epirubicin—breast cancer	6.33e-05	0.000193	CcSEcCtD
Cilazapril—Dysgeusia—Epirubicin—breast cancer	6.32e-05	0.000192	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—TFRC—breast cancer	6.31e-05	0.00122	CbGpPWpGaD
Cilazapril—Diarrhoea—Paclitaxel—breast cancer	6.3e-05	0.000192	CcSEcCtD
Cilazapril—Nervousness—Epirubicin—breast cancer	6.26e-05	0.000191	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC5A5—breast cancer	6.24e-05	0.00121	CbGpPWpGaD
Cilazapril—Feeling abnormal—Capecitabine—breast cancer	6.23e-05	0.00019	CcSEcCtD
Cilazapril—Angiopathy—Doxorubicin—breast cancer	6.22e-05	0.000189	CcSEcCtD
Cilazapril—Malaise—Methotrexate—breast cancer	6.21e-05	0.000189	CcSEcCtD
Cilazapril—Muscle spasms—Epirubicin—breast cancer	6.2e-05	0.000189	CcSEcCtD
Cilazapril—Immune system disorder—Doxorubicin—breast cancer	6.19e-05	0.000189	CcSEcCtD
Cilazapril—Vertigo—Methotrexate—breast cancer	6.19e-05	0.000189	CcSEcCtD
Cilazapril—Gastrointestinal pain—Capecitabine—breast cancer	6.18e-05	0.000188	CcSEcCtD
Cilazapril—Abdominal pain—Docetaxel—breast cancer	6.17e-05	0.000188	CcSEcCtD
Cilazapril—Leukopenia—Methotrexate—breast cancer	6.17e-05	0.000188	CcSEcCtD
Cilazapril—Chills—Doxorubicin—breast cancer	6.15e-05	0.000187	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—breast cancer	6.15e-05	0.00119	CbGpPWpGaD
Cilazapril—Arrhythmia—Doxorubicin—breast cancer	6.12e-05	0.000187	CcSEcCtD
Cilazapril—Dizziness—Paclitaxel—breast cancer	6.09e-05	0.000185	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—NCOA2—breast cancer	6.07e-05	0.00118	CbGpPWpGaD
Cilazapril—Alopecia—Doxorubicin—breast cancer	6.06e-05	0.000185	CcSEcCtD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—FOS—breast cancer	6.05e-05	0.00117	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC2A1—breast cancer	6.03e-05	0.00117	CbGpPWpGaD
Cilazapril—Cough—Methotrexate—breast cancer	6.01e-05	0.000183	CcSEcCtD
Cilazapril—Urticaria—Capecitabine—breast cancer	6e-05	0.000183	CcSEcCtD
Cilazapril—Ill-defined disorder—Epirubicin—breast cancer	5.98e-05	0.000182	CcSEcCtD
Cilazapril—Abdominal pain—Capecitabine—breast cancer	5.97e-05	0.000182	CcSEcCtD
Cilazapril—Anaemia—Epirubicin—breast cancer	5.96e-05	0.000182	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—breast cancer	5.91e-05	0.00115	CbGpPWpGaD
Cilazapril—Flatulence—Doxorubicin—breast cancer	5.88e-05	0.000179	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—breast cancer	5.87e-05	0.00114	CbGpPWpGaD
Cilazapril—Arthralgia—Methotrexate—breast cancer	5.87e-05	0.000179	CcSEcCtD
Cilazapril—Chest pain—Methotrexate—breast cancer	5.87e-05	0.000179	CcSEcCtD
Cilazapril—Myalgia—Methotrexate—breast cancer	5.87e-05	0.000179	CcSEcCtD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—ALB—breast cancer	5.86e-05	0.00114	CbGpPWpGaD
Cilazapril—Tension—Doxorubicin—breast cancer	5.86e-05	0.000178	CcSEcCtD
Cilazapril—Vomiting—Paclitaxel—breast cancer	5.85e-05	0.000178	CcSEcCtD
Cilazapril—Dysgeusia—Doxorubicin—breast cancer	5.84e-05	0.000178	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.83e-05	0.000178	CcSEcCtD
Cilazapril—Malaise—Epirubicin—breast cancer	5.82e-05	0.000177	CcSEcCtD
Cilazapril—Rash—Paclitaxel—breast cancer	5.8e-05	0.000177	CcSEcCtD
Cilazapril—Dermatitis—Paclitaxel—breast cancer	5.8e-05	0.000177	CcSEcCtD
Cilazapril—Discomfort—Methotrexate—breast cancer	5.8e-05	0.000177	CcSEcCtD
Cilazapril—Nervousness—Doxorubicin—breast cancer	5.8e-05	0.000177	CcSEcCtD
Cilazapril—Vertigo—Epirubicin—breast cancer	5.79e-05	0.000177	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC5A5—breast cancer	5.79e-05	0.00112	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—breast cancer	5.79e-05	0.00112	CbGpPWpGaD
Cilazapril—Syncope—Epirubicin—breast cancer	5.78e-05	0.000176	CcSEcCtD
Cilazapril—Leukopenia—Epirubicin—breast cancer	5.77e-05	0.000176	CcSEcCtD
Cilazapril—Headache—Paclitaxel—breast cancer	5.77e-05	0.000176	CcSEcCtD
Cilazapril—Hypersensitivity—Docetaxel—breast cancer	5.75e-05	0.000175	CcSEcCtD
Cilazapril—Muscle spasms—Doxorubicin—breast cancer	5.74e-05	0.000175	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—breast cancer	5.73e-05	0.00111	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—MMP1—breast cancer	5.72e-05	0.00111	CbGpPWpGaD
Cilazapril—Palpitations—Epirubicin—breast cancer	5.7e-05	0.000174	CcSEcCtD
Cilazapril—Confusional state—Methotrexate—breast cancer	5.67e-05	0.000173	CcSEcCtD
Cilazapril—Loss of consciousness—Epirubicin—breast cancer	5.67e-05	0.000173	CcSEcCtD
Cilazapril—Cough—Epirubicin—breast cancer	5.63e-05	0.000171	CcSEcCtD
Cilazapril—Asthenia—Docetaxel—breast cancer	5.6e-05	0.000171	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC2A1—breast cancer	5.59e-05	0.00109	CbGpPWpGaD
Cilazapril—Hypertension—Epirubicin—breast cancer	5.57e-05	0.00017	CcSEcCtD
Cilazapril—Hypersensitivity—Capecitabine—breast cancer	5.57e-05	0.00017	CcSEcCtD
Cilazapril—Ill-defined disorder—Doxorubicin—breast cancer	5.54e-05	0.000169	CcSEcCtD
Cilazapril—ACE—Metabolism of proteins—LEP—breast cancer	5.53e-05	0.00107	CbGpPWpGaD
Cilazapril—Pruritus—Docetaxel—breast cancer	5.52e-05	0.000168	CcSEcCtD
Cilazapril—Anaemia—Doxorubicin—breast cancer	5.52e-05	0.000168	CcSEcCtD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—breast cancer	5.51e-05	0.00107	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—NCOA1—breast cancer	5.51e-05	0.00107	CbGpPWpGaD
Cilazapril—Thrombocytopenia—Methotrexate—breast cancer	5.51e-05	0.000168	CcSEcCtD
Cilazapril—Arthralgia—Epirubicin—breast cancer	5.49e-05	0.000167	CcSEcCtD
Cilazapril—Chest pain—Epirubicin—breast cancer	5.49e-05	0.000167	CcSEcCtD
Cilazapril—Myalgia—Epirubicin—breast cancer	5.49e-05	0.000167	CcSEcCtD
Cilazapril—Anxiety—Epirubicin—breast cancer	5.47e-05	0.000167	CcSEcCtD
Cilazapril—Nausea—Paclitaxel—breast cancer	5.47e-05	0.000167	CcSEcCtD
Cilazapril—Skin disorder—Methotrexate—breast cancer	5.46e-05	0.000166	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	5.45e-05	0.000166	CcSEcCtD
Cilazapril—Hyperhidrosis—Methotrexate—breast cancer	5.44e-05	0.000166	CcSEcCtD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—ALB—breast cancer	5.44e-05	0.00106	CbGpPWpGaD
Cilazapril—Discomfort—Epirubicin—breast cancer	5.42e-05	0.000165	CcSEcCtD
Cilazapril—Asthenia—Capecitabine—breast cancer	5.42e-05	0.000165	CcSEcCtD
Cilazapril—Malaise—Doxorubicin—breast cancer	5.38e-05	0.000164	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—PLG—breast cancer	5.37e-05	0.00104	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—breast cancer	5.37e-05	0.00104	CbGpPWpGaD
Cilazapril—Dry mouth—Epirubicin—breast cancer	5.37e-05	0.000164	CcSEcCtD
Cilazapril—Vertigo—Doxorubicin—breast cancer	5.36e-05	0.000163	CcSEcCtD
Cilazapril—Anorexia—Methotrexate—breast cancer	5.36e-05	0.000163	CcSEcCtD
Cilazapril—ABCB1—Transmembrane transport of small molecules—COX11—breast cancer	5.36e-05	0.00104	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC39A7—breast cancer	5.36e-05	0.00104	CbGpPWpGaD
Cilazapril—Syncope—Doxorubicin—breast cancer	5.35e-05	0.000163	CcSEcCtD
Cilazapril—Pruritus—Capecitabine—breast cancer	5.35e-05	0.000163	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP7—breast cancer	5.34e-05	0.00104	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—THBS1—breast cancer	5.34e-05	0.00104	CbGpPWpGaD
Cilazapril—Leukopenia—Doxorubicin—breast cancer	5.34e-05	0.000163	CcSEcCtD
Cilazapril—Diarrhoea—Docetaxel—breast cancer	5.34e-05	0.000163	CcSEcCtD
Cilazapril—Confusional state—Epirubicin—breast cancer	5.31e-05	0.000162	CcSEcCtD
Cilazapril—Palpitations—Doxorubicin—breast cancer	5.27e-05	0.000161	CcSEcCtD
Cilazapril—Oedema—Epirubicin—breast cancer	5.26e-05	0.00016	CcSEcCtD
Cilazapril—Hypotension—Methotrexate—breast cancer	5.26e-05	0.00016	CcSEcCtD
Cilazapril—Loss of consciousness—Doxorubicin—breast cancer	5.24e-05	0.00016	CcSEcCtD
Cilazapril—Cough—Doxorubicin—breast cancer	5.21e-05	0.000159	CcSEcCtD
Cilazapril—Shock—Epirubicin—breast cancer	5.18e-05	0.000158	CcSEcCtD
Cilazapril—Diarrhoea—Capecitabine—breast cancer	5.17e-05	0.000157	CcSEcCtD
Cilazapril—Dizziness—Docetaxel—breast cancer	5.16e-05	0.000157	CcSEcCtD
Cilazapril—Thrombocytopenia—Epirubicin—breast cancer	5.15e-05	0.000157	CcSEcCtD
Cilazapril—Hypertension—Doxorubicin—breast cancer	5.15e-05	0.000157	CcSEcCtD
Cilazapril—Tachycardia—Epirubicin—breast cancer	5.14e-05	0.000157	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Methotrexate—breast cancer	5.12e-05	0.000156	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—NCOA1—breast cancer	5.12e-05	0.000993	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CASP8—breast cancer	5.12e-05	0.000993	CbGpPWpGaD
Cilazapril—Skin disorder—Epirubicin—breast cancer	5.11e-05	0.000156	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—breast cancer	5.1e-05	0.00099	CbGpPWpGaD
Cilazapril—Hyperhidrosis—Epirubicin—breast cancer	5.09e-05	0.000155	CcSEcCtD
Cilazapril—Insomnia—Methotrexate—breast cancer	5.09e-05	0.000155	CcSEcCtD
Cilazapril—Chest pain—Doxorubicin—breast cancer	5.08e-05	0.000155	CcSEcCtD
Cilazapril—Arthralgia—Doxorubicin—breast cancer	5.08e-05	0.000155	CcSEcCtD
Cilazapril—Myalgia—Doxorubicin—breast cancer	5.08e-05	0.000155	CcSEcCtD
Cilazapril—Anxiety—Doxorubicin—breast cancer	5.06e-05	0.000154	CcSEcCtD
Cilazapril—Paraesthesia—Methotrexate—breast cancer	5.05e-05	0.000154	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	5.05e-05	0.000154	CcSEcCtD
Cilazapril—Discomfort—Doxorubicin—breast cancer	5.02e-05	0.000153	CcSEcCtD
Cilazapril—Anorexia—Epirubicin—breast cancer	5.02e-05	0.000153	CcSEcCtD
Cilazapril—Dyspnoea—Methotrexate—breast cancer	5.01e-05	0.000153	CcSEcCtD
Cilazapril—Somnolence—Methotrexate—breast cancer	5e-05	0.000152	CcSEcCtD
Cilazapril—Dizziness—Capecitabine—breast cancer	5e-05	0.000152	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—PLG—breast cancer	4.99e-05	0.000968	CbGpPWpGaD
Cilazapril—Dry mouth—Doxorubicin—breast cancer	4.97e-05	0.000151	CcSEcCtD
Cilazapril—Vomiting—Docetaxel—breast cancer	4.96e-05	0.000151	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—HMOX1—breast cancer	4.96e-05	0.000962	CbGpPWpGaD
Cilazapril—Dyspepsia—Methotrexate—breast cancer	4.95e-05	0.000151	CcSEcCtD
Cilazapril—Rash—Docetaxel—breast cancer	4.92e-05	0.00015	CcSEcCtD
Cilazapril—Hypotension—Epirubicin—breast cancer	4.92e-05	0.00015	CcSEcCtD
Cilazapril—Dermatitis—Docetaxel—breast cancer	4.92e-05	0.00015	CcSEcCtD
Cilazapril—Confusional state—Doxorubicin—breast cancer	4.91e-05	0.00015	CcSEcCtD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC22A18—breast cancer	4.9e-05	0.000951	CbGpPWpGaD
Cilazapril—Decreased appetite—Methotrexate—breast cancer	4.89e-05	0.000149	CcSEcCtD
Cilazapril—Headache—Docetaxel—breast cancer	4.89e-05	0.000149	CcSEcCtD
Cilazapril—Oedema—Doxorubicin—breast cancer	4.87e-05	0.000148	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Methotrexate—breast cancer	4.86e-05	0.000148	CcSEcCtD
Cilazapril—Fatigue—Methotrexate—breast cancer	4.85e-05	0.000148	CcSEcCtD
Cilazapril—Pain—Methotrexate—breast cancer	4.81e-05	0.000147	CcSEcCtD
Cilazapril—Vomiting—Capecitabine—breast cancer	4.8e-05	0.000146	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Epirubicin—breast cancer	4.8e-05	0.000146	CcSEcCtD
Cilazapril—Shock—Doxorubicin—breast cancer	4.79e-05	0.000146	CcSEcCtD
Cilazapril—Thrombocytopenia—Doxorubicin—breast cancer	4.77e-05	0.000145	CcSEcCtD
Cilazapril—Rash—Capecitabine—breast cancer	4.76e-05	0.000145	CcSEcCtD
Cilazapril—Insomnia—Epirubicin—breast cancer	4.76e-05	0.000145	CcSEcCtD
Cilazapril—Dermatitis—Capecitabine—breast cancer	4.76e-05	0.000145	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ABCB1—breast cancer	4.76e-05	0.000924	CbGpPWpGaD
Cilazapril—Tachycardia—Doxorubicin—breast cancer	4.75e-05	0.000145	CcSEcCtD
Cilazapril—Headache—Capecitabine—breast cancer	4.73e-05	0.000144	CcSEcCtD
Cilazapril—Skin disorder—Doxorubicin—breast cancer	4.73e-05	0.000144	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PAK1—breast cancer	4.73e-05	0.000918	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—breast cancer	4.73e-05	0.000918	CbGpPWpGaD
Cilazapril—Paraesthesia—Epirubicin—breast cancer	4.73e-05	0.000144	CcSEcCtD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC2A5—breast cancer	4.72e-05	0.000915	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLCO1B1—breast cancer	4.72e-05	0.000915	CbGpPWpGaD
Cilazapril—Hyperhidrosis—Doxorubicin—breast cancer	4.71e-05	0.000143	CcSEcCtD
Cilazapril—Dyspnoea—Epirubicin—breast cancer	4.69e-05	0.000143	CcSEcCtD
Cilazapril—Somnolence—Epirubicin—breast cancer	4.68e-05	0.000143	CcSEcCtD
Cilazapril—Anorexia—Doxorubicin—breast cancer	4.64e-05	0.000141	CcSEcCtD
Cilazapril—Nausea—Docetaxel—breast cancer	4.64e-05	0.000141	CcSEcCtD
Cilazapril—Feeling abnormal—Methotrexate—breast cancer	4.63e-05	0.000141	CcSEcCtD
Cilazapril—Dyspepsia—Epirubicin—breast cancer	4.63e-05	0.000141	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—HMOX1—breast cancer	4.6e-05	0.000893	CbGpPWpGaD
Cilazapril—Gastrointestinal pain—Methotrexate—breast cancer	4.6e-05	0.00014	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—breast cancer	4.58e-05	0.000889	CbGpPWpGaD
Cilazapril—Decreased appetite—Epirubicin—breast cancer	4.58e-05	0.000139	CcSEcCtD
Cilazapril—ACE—Metabolism of proteins—IGF1—breast cancer	4.57e-05	0.000888	CbGpPWpGaD
Cilazapril—Hypotension—Doxorubicin—breast cancer	4.55e-05	0.000139	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Epirubicin—breast cancer	4.54e-05	0.000138	CcSEcCtD
Cilazapril—Fatigue—Epirubicin—breast cancer	4.54e-05	0.000138	CcSEcCtD
Cilazapril—Constipation—Epirubicin—breast cancer	4.5e-05	0.000137	CcSEcCtD
Cilazapril—Pain—Epirubicin—breast cancer	4.5e-05	0.000137	CcSEcCtD
Cilazapril—Nausea—Capecitabine—breast cancer	4.49e-05	0.000137	CcSEcCtD
Cilazapril—Urticaria—Methotrexate—breast cancer	4.47e-05	0.000136	CcSEcCtD
Cilazapril—Abdominal pain—Methotrexate—breast cancer	4.45e-05	0.000135	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Doxorubicin—breast cancer	4.44e-05	0.000135	CcSEcCtD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—breast cancer	4.43e-05	0.00086	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—MMP2—breast cancer	4.43e-05	0.000859	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—breast cancer	4.42e-05	0.000858	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ABCB1—breast cancer	4.42e-05	0.000857	CbGpPWpGaD
Cilazapril—Insomnia—Doxorubicin—breast cancer	4.4e-05	0.000134	CcSEcCtD
Cilazapril—Paraesthesia—Doxorubicin—breast cancer	4.37e-05	0.000133	CcSEcCtD
Cilazapril—ABCB1—Allograft Rejection—IFNG—breast cancer	4.35e-05	0.000844	CbGpPWpGaD
Cilazapril—Dyspnoea—Doxorubicin—breast cancer	4.34e-05	0.000132	CcSEcCtD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—JUN—breast cancer	4.34e-05	0.000843	CbGpPWpGaD
Cilazapril—Feeling abnormal—Epirubicin—breast cancer	4.34e-05	0.000132	CcSEcCtD
Cilazapril—Somnolence—Doxorubicin—breast cancer	4.33e-05	0.000132	CcSEcCtD
Cilazapril—Gastrointestinal pain—Epirubicin—breast cancer	4.3e-05	0.000131	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—breast cancer	4.29e-05	0.000833	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—breast cancer	4.29e-05	0.000833	CbGpPWpGaD
Cilazapril—Dyspepsia—Doxorubicin—breast cancer	4.29e-05	0.000131	CcSEcCtD
Cilazapril—Decreased appetite—Doxorubicin—breast cancer	4.23e-05	0.000129	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Doxorubicin—breast cancer	4.2e-05	0.000128	CcSEcCtD
Cilazapril—Fatigue—Doxorubicin—breast cancer	4.2e-05	0.000128	CcSEcCtD
Cilazapril—Urticaria—Epirubicin—breast cancer	4.18e-05	0.000127	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—AR—breast cancer	4.18e-05	0.000811	CbGpPWpGaD
Cilazapril—Pain—Doxorubicin—breast cancer	4.16e-05	0.000127	CcSEcCtD
Cilazapril—Constipation—Doxorubicin—breast cancer	4.16e-05	0.000127	CcSEcCtD
Cilazapril—Abdominal pain—Epirubicin—breast cancer	4.16e-05	0.000127	CcSEcCtD
Cilazapril—Hypersensitivity—Methotrexate—breast cancer	4.14e-05	0.000126	CcSEcCtD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC39A6—breast cancer	4.06e-05	0.000788	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CXCL8—breast cancer	4.04e-05	0.000785	CbGpPWpGaD
Cilazapril—Asthenia—Methotrexate—breast cancer	4.04e-05	0.000123	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFA—breast cancer	4.03e-05	0.000782	CbGpPWpGaD
Cilazapril—Feeling abnormal—Doxorubicin—breast cancer	4.01e-05	0.000122	CcSEcCtD
Cilazapril—Gastrointestinal pain—Doxorubicin—breast cancer	3.98e-05	0.000121	CcSEcCtD
Cilazapril—Pruritus—Methotrexate—breast cancer	3.98e-05	0.000121	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—breast cancer	3.88e-05	0.000754	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—STAT5A—breast cancer	3.88e-05	0.000754	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—breast cancer	3.88e-05	0.000754	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IL1B—breast cancer	3.88e-05	0.000753	CbGpPWpGaD
Cilazapril—Hypersensitivity—Epirubicin—breast cancer	3.88e-05	0.000118	CcSEcCtD
Cilazapril—ABCB1—Allograft Rejection—CASP3—breast cancer	3.87e-05	0.000751	CbGpPWpGaD
Cilazapril—Urticaria—Doxorubicin—breast cancer	3.87e-05	0.000118	CcSEcCtD
Cilazapril—ABCB1—Allograft Rejection—IL2—breast cancer	3.87e-05	0.00075	CbGpPWpGaD
Cilazapril—Abdominal pain—Doxorubicin—breast cancer	3.85e-05	0.000117	CcSEcCtD
Cilazapril—Diarrhoea—Methotrexate—breast cancer	3.85e-05	0.000117	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—breast cancer	3.81e-05	0.000739	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—breast cancer	3.79e-05	0.000736	CbGpPWpGaD
Cilazapril—Asthenia—Epirubicin—breast cancer	3.78e-05	0.000115	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—breast cancer	3.76e-05	0.00073	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—breast cancer	3.76e-05	0.00073	CbGpPWpGaD
Cilazapril—Pruritus—Epirubicin—breast cancer	3.72e-05	0.000113	CcSEcCtD
Cilazapril—Dizziness—Methotrexate—breast cancer	3.72e-05	0.000113	CcSEcCtD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ATP7B—breast cancer	3.71e-05	0.000721	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—breast cancer	3.69e-05	0.000717	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—CXCL8—breast cancer	3.68e-05	0.000714	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—breast cancer	3.65e-05	0.000708	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—breast cancer	3.61e-05	0.000701	CbGpPWpGaD
Cilazapril—Diarrhoea—Epirubicin—breast cancer	3.6e-05	0.00011	CcSEcCtD
Cilazapril—Hypersensitivity—Doxorubicin—breast cancer	3.59e-05	0.000109	CcSEcCtD
Cilazapril—Vomiting—Methotrexate—breast cancer	3.58e-05	0.000109	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—breast cancer	3.56e-05	0.00069	CbGpPWpGaD
Cilazapril—Rash—Methotrexate—breast cancer	3.55e-05	0.000108	CcSEcCtD
Cilazapril—Dermatitis—Methotrexate—breast cancer	3.54e-05	0.000108	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—breast cancer	3.53e-05	0.000686	CbGpPWpGaD
Cilazapril—Headache—Methotrexate—breast cancer	3.52e-05	0.000107	CcSEcCtD
Cilazapril—Asthenia—Doxorubicin—breast cancer	3.49e-05	0.000106	CcSEcCtD
Cilazapril—Dizziness—Epirubicin—breast cancer	3.48e-05	0.000106	CcSEcCtD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ABCC1—breast cancer	3.45e-05	0.00067	CbGpPWpGaD
Cilazapril—Pruritus—Doxorubicin—breast cancer	3.45e-05	0.000105	CcSEcCtD
Cilazapril—ACE—Metabolism of proteins—CTNNB1—breast cancer	3.39e-05	0.000659	CbGpPWpGaD
Cilazapril—Vomiting—Epirubicin—breast cancer	3.35e-05	0.000102	CcSEcCtD
Cilazapril—Nausea—Methotrexate—breast cancer	3.34e-05	0.000102	CcSEcCtD
Cilazapril—Diarrhoea—Doxorubicin—breast cancer	3.33e-05	0.000102	CcSEcCtD
Cilazapril—Rash—Epirubicin—breast cancer	3.32e-05	0.000101	CcSEcCtD
Cilazapril—Dermatitis—Epirubicin—breast cancer	3.32e-05	0.000101	CcSEcCtD
Cilazapril—Headache—Epirubicin—breast cancer	3.3e-05	0.0001	CcSEcCtD
Cilazapril—ABCB1—Allograft Rejection—VEGFA—breast cancer	3.29e-05	0.000638	CbGpPWpGaD
Cilazapril—Dizziness—Doxorubicin—breast cancer	3.22e-05	9.81e-05	CcSEcCtD
Cilazapril—Nausea—Epirubicin—breast cancer	3.13e-05	9.53e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—breast cancer	3.12e-05	0.000606	CbGpPWpGaD
Cilazapril—Vomiting—Doxorubicin—breast cancer	3.1e-05	9.43e-05	CcSEcCtD
Cilazapril—Rash—Doxorubicin—breast cancer	3.07e-05	9.36e-05	CcSEcCtD
Cilazapril—Dermatitis—Doxorubicin—breast cancer	3.07e-05	9.35e-05	CcSEcCtD
Cilazapril—Headache—Doxorubicin—breast cancer	3.05e-05	9.3e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—breast cancer	3.05e-05	0.000591	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SYNJ2—breast cancer	3.03e-05	0.000588	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—TGFB1—breast cancer	3.02e-05	0.000585	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ALB—breast cancer	2.98e-05	0.000578	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—TUBB3—breast cancer	2.93e-05	0.00057	CbGpPWpGaD
Cilazapril—Nausea—Doxorubicin—breast cancer	2.89e-05	8.81e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—breast cancer	2.89e-05	0.000561	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—breast cancer	2.88e-05	0.000559	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—breast cancer	2.87e-05	0.000557	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—TNF—breast cancer	2.82e-05	0.000546	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NDUFS3—breast cancer	2.81e-05	0.000546	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—breast cancer	2.8e-05	0.000543	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ALB—breast cancer	2.76e-05	0.000536	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—APC—breast cancer	2.71e-05	0.000526	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—RAF1—breast cancer	2.69e-05	0.000522	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—breast cancer	2.68e-05	0.00052	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CHST9—breast cancer	2.65e-05	0.000514	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—breast cancer	2.52e-05	0.00049	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—COX11—breast cancer	2.51e-05	0.000487	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—RAF1—breast cancer	2.5e-05	0.000485	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—breast cancer	2.48e-05	0.000482	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC2A2—breast cancer	2.44e-05	0.000474	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—AKT1—breast cancer	2.42e-05	0.00047	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ABCG2—breast cancer	2.39e-05	0.000464	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SHMT1—breast cancer	2.29e-05	0.000445	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CDA—breast cancer	2.29e-05	0.000445	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SLC2A5—breast cancer	2.21e-05	0.000429	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SLCO1B1—breast cancer	2.21e-05	0.000429	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—breast cancer	2.17e-05	0.00042	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—breast cancer	2.13e-05	0.000414	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—APRT—breast cancer	2.13e-05	0.000414	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—TFRC—breast cancer	2.13e-05	0.000414	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—breast cancer	2.13e-05	0.000413	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—breast cancer	2.1e-05	0.000408	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—breast cancer	2.06e-05	0.000399	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—NCOA2—breast cancer	2.05e-05	0.000398	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ESRRA—breast cancer	2.01e-05	0.000389	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ANGPTL4—breast cancer	2.01e-05	0.000389	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC5A5—breast cancer	1.96e-05	0.00038	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—breast cancer	1.95e-05	0.000378	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	1.91e-05	0.000371	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GPI—breast cancer	1.9e-05	0.000369	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HADHB—breast cancer	1.9e-05	0.000369	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC2A1—breast cancer	1.89e-05	0.000367	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	1.86e-05	0.000361	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	1.86e-05	0.00036	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	1.84e-05	0.000357	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ALDH1A1—breast cancer	1.81e-05	0.000352	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ALDH7A1—breast cancer	1.81e-05	0.000352	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	1.8e-05	0.000349	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	1.79e-05	0.000348	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	1.76e-05	0.000341	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—FHL2—breast cancer	1.74e-05	0.000337	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NME1—breast cancer	1.74e-05	0.000337	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PHGDH—breast cancer	1.74e-05	0.000337	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ADSL—breast cancer	1.74e-05	0.000337	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—UMPS—breast cancer	1.74e-05	0.000337	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—NCOA1—breast cancer	1.73e-05	0.000336	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HPSE—breast cancer	1.71e-05	0.000331	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—BRIP1—breast cancer	1.71e-05	0.000331	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—LDHB—breast cancer	1.71e-05	0.000331	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—PLG—breast cancer	1.69e-05	0.000327	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	1.66e-05	0.000323	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	1.62e-05	0.000315	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ABCC1—breast cancer	1.62e-05	0.000314	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HMMR—breast cancer	1.62e-05	0.000314	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTA3—breast cancer	1.62e-05	0.000314	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PPARGC1B—breast cancer	1.57e-05	0.000304	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—HMOX1—breast cancer	1.56e-05	0.000302	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	1.53e-05	0.000298	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	1.49e-05	0.000289	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	1.49e-05	0.000289	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CA9—breast cancer	1.48e-05	0.000287	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTA4—breast cancer	1.48e-05	0.000287	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	1.46e-05	0.000283	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTA2—breast cancer	1.44e-05	0.00028	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GPX2—breast cancer	1.44e-05	0.00028	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GPX4—breast cancer	1.42e-05	0.000276	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SULT1A1—breast cancer	1.42e-05	0.000276	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—IDH1—breast cancer	1.39e-05	0.00027	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTA1—breast cancer	1.39e-05	0.00027	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	1.39e-05	0.00027	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	1.38e-05	0.000267	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NAT2—breast cancer	1.37e-05	0.000267	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	1.27e-05	0.000246	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	1.22e-05	0.000238	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—MED12—breast cancer	1.21e-05	0.000234	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—DPYD—breast cancer	1.21e-05	0.000234	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ALDOA—breast cancer	1.19e-05	0.00023	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NCOA3—breast cancer	1.15e-05	0.000224	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SLC2A2—breast cancer	1.14e-05	0.000222	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ABCG2—breast cancer	1.12e-05	0.000217	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—MTR—breast cancer	1.12e-05	0.000217	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CPT1A—breast cancer	1.12e-05	0.000217	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HPGDS—breast cancer	1.1e-05	0.000213	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HBA1—breast cancer	1.09e-05	0.000212	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTT1—breast cancer	1.07e-05	0.000207	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ACHE—breast cancer	1.07e-05	0.000207	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.03e-05	0.000201	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP17A1—breast cancer	1.01e-05	0.000196	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PTGS1—breast cancer	9.99e-06	0.000194	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ENO1—breast cancer	9.99e-06	0.000194	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP2D6—breast cancer	9.79e-06	0.00019	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NCOA2—breast cancer	9.61e-06	0.000187	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	9.34e-06	0.000181	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—FASN—breast cancer	9.32e-06	0.000181	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—BCHE—breast cancer	9.28e-06	0.00018	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SLC5A5—breast cancer	9.17e-06	0.000178	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SLC2A1—breast cancer	8.86e-06	0.000172	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NQO1—breast cancer	8.86e-06	0.000172	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP3A4—breast cancer	8.64e-06	0.000168	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP1B1—breast cancer	8.49e-06	0.000165	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	8.45e-06	0.000164	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HSP90AA1—breast cancer	8.33e-06	0.000162	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NCOA1—breast cancer	8.1e-06	0.000157	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP19A1—breast cancer	7.98e-06	0.000155	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—STK11—breast cancer	7.98e-06	0.000155	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—COMT—breast cancer	7.42e-06	0.000144	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTP1—breast cancer	7.39e-06	0.000143	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HMOX1—breast cancer	7.29e-06	0.000141	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ITPR1—breast cancer	7.27e-06	0.000141	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—TYMS—breast cancer	6.87e-06	0.000133	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NCOR1—breast cancer	6.79e-06	0.000132	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PLA2G4A—breast cancer	6.79e-06	0.000132	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTM1—breast cancer	6.79e-06	0.000132	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GPX1—breast cancer	6.5e-06	0.000126	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP1A1—breast cancer	6.44e-06	0.000125	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ERCC2—breast cancer	6.38e-06	0.000124	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—MTHFR—breast cancer	6e-06	0.000116	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CAV1—breast cancer	5.53e-06	0.000107	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PIK3CG—breast cancer	5.04e-06	9.78e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PIK3CD—breast cancer	4.43e-06	8.6e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ALB—breast cancer	4.37e-06	8.49e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NOS3—breast cancer	4.18e-06	8.12e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PIK3CB—breast cancer	3.86e-06	7.5e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PTGS2—breast cancer	3.83e-06	7.43e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PTEN—breast cancer	3.34e-06	6.48e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PIK3CA—breast cancer	2.35e-06	4.57e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—AKT1—breast cancer	1.92e-06	3.73e-05	CbGpPWpGaD
